Deferred Tax Assets, Net of Valuation Allowance of ENZO BIOCHEM INC from 31 Jul 2020 to 31 Jul 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: ENZO BIOCHEM INC quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Jul 2020 to 31 Jul 2024.
ENZO BIOCHEM INC Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Jul 2024 was $29,662,000, a 11% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

ENZO BIOCHEM INC Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$29,662,000	+$2,977,000	+11%	31 Jul 2024	10-K	29 Oct 2024	2024	FY
Q2 2023	$26,685,000	-$7,925,000	-23%	31 Jul 2023	10-K	29 Oct 2024	2024	FY
Q2 2022	$34,610,000	+$4,736,000	+16%	31 Jul 2022	10-K	14 Oct 2022	2022	FY
Q2 2021	$29,874,000	-$203,000	-0.68%	31 Jul 2021	10-K	14 Oct 2022	2022	FY
Q2 2020	$30,077,000			31 Jul 2020	10-K	12 Oct 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.